GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation
Trident Medical Center Joins Sarah Cannon Research Institute in National Early Cancer Detection Study
GRAIL Announces Appointment of Key Executives as Company Makes Continued Progress in Development of Early Detection Products
